Robotic Surgery Now Affordable for Cancer Patients

Robotic-assisted cancer surgery, once hindered by high costs and extensive infrastructure needs, is now within reach for more patients. This accessibility is largely due to robust institutional support, generous donor funding, and a carefully implemented subsidized care model.

At The Adyar Cancer Institute, a remarkable nearly 60% of all robotic-assisted cancer surgeries performed have been part of free and subsidized treatment programs. These advanced procedures encompass a range of cancers, including thoracic, head and neck, colorectal, urological, and gynecological malignancies, all performed using the sophisticated da Vinci Surgical System.

The institute has also developed specialized expertise in transoral robotic surgery (TORS) for head and neck cancers, a technique available at only a few centers across India. Crucially, all surgical cases undergo rigorous review by multidisciplinary tumor boards, ensuring clinical selection criteria are meticulously maintained.

This program has opened doors for patients from lower and middle-income backgrounds to access cutting-edge surgical interventions. Experts highlight that robotic surgery, when selected appropriately, provides enhanced precision, leads to reduced blood loss, and often results in shorter hospitalizations, ultimately improving patient outcomes and recovery.